Why so many men are bad at retirement. Read more
Démanteler ou tolérer les campements de sans-abris? La question divise les villes. Lire ici
Category:
Published on: 29 Apr 2024
«Ça m’aide vraiment à apprécier la vie»: les antidépresseurs rendent-ils vraiment heureux? Lire ici
Category:
Published on: 11 Apr 2024
Dr. Gabriella Gobbi has been elected as the new President of the International College of Neuropsychopharmacology (CINP). It is a historic moment for CINP to elect its first woman President.
Category:
Published on: 5 Apr 2024
Did your ancestry or DNA test lead to a surprising discovery? Read more
Category:
Published on: 13 Mar 2024
Single dose of LSD provides immediate and lasting relief from anxiety, study says. Read more
Category:
Published on: 11 Mar 2024
microRNAs as a diagnostic and prognostic biomarker for psychiatric disorders. Read more
Category:
Published on: 11 Mar 2024
What’s Ozempic doing to our brains? Vox
Breakthrough study: Cocaine cravings reduced with special shake, hints at addiction treatment possibilities. BNN Breaking
Category:
Published on: 11 Mar 2024
Depression risks of menopause have been overstated, study finds. Read moreD
Category:
Published on: 11 Mar 2024
Dr. Brett Thombs is the successful awardee of the CPA-CAPE Alex Leighton Award 2024. The Alex Leighton Award is a joint initiative of the Canadian Psychiatric Association (CPA) and the Canadian Academy of Psychiatric Epidemiology (CAPE).
Category:
Published on: 11 Mar 2024
Decoding the effects of early life adversity on mental health. Read more
Category:
Published on: 22 Feb 2024
Dr. Cecile Rousseau has been nominated as the new Director of the Division of Child and Adolescent Psychiatry (CAP), effective March 1, 2024.
As Director of the Division of CAP, Dr. Rousseau will work in close collaboration with the Departmental academic leadership, clinical chiefs and Research Institute Directors to manage the oversight and academic activities of the division, including education and research.
Category:
Published on: 16 Feb 2024
Dr. Delphine Raucher-Chéné for her project, entitled, Minds@Work for individuals with bipolar disorder and Dr. Kyle Greenway for his project, entitled, Ketamine as a Novel Treatment Option for Postpartum Depression: A Feasibility Case Series were each awarded $25,000 for their research projects relating to the implementation of clinical innovations in patient care. Congratulations!
Category:
Published on: 16 Feb 2024
Montreal's largest social housing project offers affordable leases to city's vulnerable. CBC
Category:
Published on: 13 Feb 2024
Comment aider un employé qui vit un épisode psychotique. Lire ici
Category:
Published on: 13 Feb 2024
Pages
